LSI USA '25 Almost at Capacity: Register Today arrow-icon

Overview

Valued at ~$5.89 billion in 2023, the transcatheter aortic valve devices market is projected to reach ~$8.38 billion by 2028, increasing at a CAGR of 7.3% over the 2023-2028 forecast period. This Market Snapshot is part of LSI’s Market Intelligence platform, your one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and deal-tracking, curated insights, and more.
Transcatheter aortic valve devices are used to replace or repair the natural tissue valve of the heart, particularly the aortic valve, which may be damaged due to disease or aging. Transcatheter aortic valve replacement (TAVR), or transcatheter aortic valve implantation (TAVI), involves delivering a fully collapsible replacement valve through a catheter. Once inside the heart, the valve is deployed into its natural position by inflating a balloon, allowing it to function within the patient’s diseased valve.
Products included within the scope of this analysis include:
Transcatheter aortic valve repair and replacement devices
This Market Snapshot is intended to provide a high-level overview of the global market for transcatheter aortic valve devices, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups

Transcatheter Aortic Valve Devices Market Snapshot Summary

Snapshot Aspect Data and Details
Base Year for Estimate 2023
Forecast Period 2023 - 2028
Market Size in 2023 $5.89 billion
CAGR 7.3%
Projected Market Size in 2028 $8.38 billion

Transcatheter Aortic Valve Devices Market Insights

The transcatheter aortic valve market is the largest segment within the overall heart valve market, which includes mechanical heart valves, tissue heart valves, and transcatheter mitral, tricuspid, and pulmonary valves. Over the past few years, this segment has seen rapid growth driven by the increasing adoption of less invasive transcatheter aortic valve repair and replacement procedures. These procedures have enabled treatment for a broader range of patients, particularly those who are too frail or not candidates for traditional open-heart surgery. However, the market is showing signs of maturing as the technology becomes more widely adopted.
Total heart valve repair and replacement procedures are expected to grow at a 5.5% compound annual rate from 2023 to 2028, reflecting the increasing prevalence of heart valve disease globally. As the population ages, with more than 5 million Americans diagnosed annually and a significant portion suffering from severe aortic stenosis, the demand for transcatheter aortic valve procedures is expected to rise. This growth is further fueled by the expanding use of less invasive technologies, which allow more patients to be treated effectively and safely.

Competitive Landscape

The full Market Snapshot includes a robust analysis of the competitive landscape for the transcatheter aortic valve devices market. This includes estimated market revenue and market share for key players, such as Edwards Lifesciences and Medtronic.
Transcatheter aortic valve devices market competitor breakdown.

Select Market Events

Company Date Type Event
Edwards Lifesciences
5/2024 Product Launch Edwards announced the launch of its SAPIEN 3 Ultra RESILIA Valve in Europe.
Medtronic
3/2024 Regulatory Approval Medtronic received U.S. FDA approval for its Evolut TAVR system.

Key Companies Covered

Abbott
Anteris Technologies
Edwards Lifesciences
JenaValve
Medtronic
NVT
Vascular Interventions
Buy Transcatheter Aortic Valve Devices Market Snapshot 2024-2028
Purchase Snapshot Demo the Full Platform

Order individually or subscribe and
get a complete intel platform.

Buy this report Subscribe to All Reports

Trusted By The Companies Pioneering What’s Next

lsi logo
Contact Us Customer Login

Events

Explore Media

Market Intelligence

Resources

Market Intelligence

Schedule an exploratory call

Request Info

17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647

714-847-3540

© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy